Experts from pharma industry share their opinions and viewpoints on important issues relating to new trends, technologies, management insights and strategies in this section.
Junaid Kashir is an Associate Professor in the Department of Biology at Khalifa University and
has previously chaired multiple research/administrative committees. He has been heavily
involved in multiple programs for training graduate clinical embryology students. Dr. Kashirs
research aims to develop therapeutic/diagnostic interventions to treat infertility and understand
embryology.
Sebastian Kleebank studied Bioengineering at the University of Applied Sciences in Juelich, followed by his Ph.D. at the RWTH Aachen, Institute for Molecular Biotechnology. In his actual position as a Product Life Cycle Manager at Eppendorf AG, Business Unit Bioprocess, he is responsible for the small-scale product portfolio. During his 12 years in the bioprocess industry, he gained a lot of experience in small scale upstream process development, including several years working in the lab.
Günther Loidl joined Bachem in 2000. He held several functions in Research and Development (R&D) and Active Pharmaceutical Ingredient Manufacturing and became Vice President R&D in 2012. Since 2015, he is CTO of the Bachem Group and a member of the Corporate Executive Committee. He studied chemistry in Regensburg (Germany) and Leeds (UK) and obtained his doctorate under the supervision of Luis Moroder at the Max Planck Institute of Biochemistry in Martinsried (Germany).
Karen Chan is a process engineer at Merck Pte Ltd. Chan has six years of experience in the biopharmaceutical industry and two years of experience in research & development. She provides technical support in areas such as process development, troubleshooting and technical training for downstream processes. Chan holds a degree in Chemical Engineering from the National University of Singapore.
Ton Rijnders is the Head of Screening at the European Lead Factory. He holds a Ph.D. in molecular biology and has an extensive experience with drug discovery in pharma, with increasing managerial and scientific responsibilities. Since November 2017, Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner Lygature.
ExpreS2ion Biotechnologies’ protein expression system ExpreS2 is an important protein expression tool in the scientist’s tool box for protein expression. The ExpreS2 platform has demonstrated in many instances its usefulness in R&D, with several ExpreS2-made proteins having now been crystallized.